Previous 10 | Next 10 |
2023-11-14 09:38:38 ET More on CV Sciences Financial information for CV Sciences For further details see: CV Sciences GAAP EPS of $0.00, revenue of $4.09M
CV Sciences, Inc. Reports Third Quarter 2023 Financial Results PR Newswire SAN DIEGO , Nov. 14, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp ex...
Laser Photonics Corporation (LASE) is expected to report for Q2 2024 QuickLogic Corporation (QUIK) is expected to report $0.08 for Q3 2023 Stryve Foods Inc. (SNAX) is expected to report $-1.65 for Q3 2023 Reata Pharmaceuticals Inc. (RETA) is expected to report $-2.15 for Q3 2023 V...
CV Sciences Inc. (CVSI) is expected to report for Q1 2024
2023-11-13 09:41:06 ET Major earnings expected before the bell on Tuesday include: Canadian Solar ( CSIQ ) The Home Depot ( HD ) Sea ( SE ) Vodafone Group Public ( VOD ) Workhorse Group ( WKHS ) For further details see: Notable earnings be...
CV SCIENCES, INC. TO ANNOUNCE THIRD QUARTER 2023 RESULTS ON NOVEMBER 14, 2023 PR Newswire SAN DIEGO , Nov. 9, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company s...
CV Sciences, Inc. Launches Reserve Sleep Gummies PR Newswire Premium sleep aid supports better sleep by combining melatonin and cannabinoids SAN DIEGO , Sept. 5, 2023 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "o...
2023-08-23 17:57:01 ET Summary The state-driven trend of legalizing cannabis is encouraging, suggesting potential federal alignment. However, relying solely on this regulatory progress is risky due to bureaucratic delays. Investing in profitable cannabis companies like Green Thumb...
2023-08-14 13:30:19 ET CV Sciences, Inc. (CVSI) Q2 2023 Earnings Conference Call August 14, 2023, 10:00 AM ET Company Participants Brendan Hawkins - IR Joseph Dowling - CEO Joerg Grasser - CFO Conference Call Participants Presentation Operat...
2023-08-14 10:30:05 ET CV Sciences press release ( OTCQB:CVSI ): Q2 GAAP EPS of -$0.01. Revenue of $4M (-3.4% Y/Y). For further details see: CV Sciences GAAP EPS of -$0.01, revenue of $4M
News, Short Squeeze, Breakout and More Instantly...
Hemp-focused CV Sciences, Inc. (OTCQB:CVSI) announced its financial results on Thursday for the year ended Dec. 31, 2023. The San Diego-based compa...
CV Sciences, Inc. Reports Fiscal Year-End 2023 Financial Results PR Newswire SAN DIEGO , March 28, 2024 /PRNewswire/ -- CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp...